IMNN
Imunon, Inc.NASDAQHealthcare$3.22-2.48%ClosedMarket Cap: $8.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.94
P/S
0.00
EV/EBITDA
-0.01
DCF Value
$3.08
FCF Yield
69496.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-406.7%
ROA
-118.0%
ROIC
-181537.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-14.64B | $-4.2M | $-4.41 | — |
| FY 2025 | $0.00 | NaN% | $-14.65B | $-14.5M | $-6.83 | — |
| Q3 2025 | $0.00 | -Infinity% | $-3.5M | $-3.4M | $-1.16 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.8M | $-2.7M | $-1.87 | — |
| Q1 2025 | $0.00 | -Infinity% | $-4.1M | $-4.1M | $-3.68 | — |
| Q4 2024 | $0.00 | -Infinity% | $-4.1M | $-4.1M | $-3.65 | — |
| FY 2024 | $0.00 | NaN% | $-19.1M | $-18.6M | $-21.10 | — |
| Q3 2024 | $0.00 | -Infinity% | $-5.0M | $-4.8M | $-4.38 | — |
| Q2 2024 | $0.00 | NaN% | $-5.0M | $-4.8M | $-6.64 | — |
| Q1 2024 | $0.00 | NaN% | $-5.0M | $-4.9M | $-6.84 | — |
| Q4 2023 | $0.00 | NaN% | $-6.0M | $-4.9M | $-6.78 | — |
| FY 2023 | $0.00 | NaN% | $-21.0M | $-19.5M | $-28.14 | — |